ARTICLE | Company News
Genzyme sales and marketing update
July 26, 2010 7:00 AM UTC
Genzyme said that as of July 21, it had enrolled 122 late-onset Pompe's disease patients in its Alglucosidase Alfa Control and Education (ACE) program, most of whom had previously been enrolled in its...